1. The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer
   Yiqi Fan et al, 2022, Cancer Management and Research CrossRef
2. Clinical value of neutrophil-to-lymphocyte ratio as a predictor of prognosis of RetroNectin®-activated cytokine-induced killer cell therapy in advanced non-small-cell lung cancer
   Lingdi Zhao et al, 2019, Immunotherapy CrossRef
3. ApoE-modified liposomes mediate the antitumour effect of survivin promoter-driven HSVtk in hepatocellular carcinoma
   Xiuli Mu et al, 2020, Cancer Gene Therapy CrossRef
4. Combining cellular immunotherapy was an optional choice for unresectable advanced HCC: A systematic review and meta-analysis
   Jing Wang et al, 2021, Clinics and Research in Hepatology and Gastroenterology CrossRef
5. PD1+ tumor associated macrophages predict poor prognosis of locally advanced esophageal squamous cell carcinoma
   Yufei Lu et al, 2019, Future Oncology CrossRef
6. Successful treatment with pazopanib plus PD-1 inhibitor and RAK cells for advanced primary hepatic angiosarcoma: a case report
   Yu Qiao et al, 2018, BMC Cancer CrossRef
7. Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis
   Jing Cao et al, 2019, World Journal of Gastroenterology CrossRef
8. Identification and Functional Analysis of EPOR+ Tumor-Associated Macrophages in Human Osteosarcoma Lung Metastasis
   Yanxing Li et al, 2020, Journal of Immunology Research CrossRef
9. Efficacy of Tumor-Infiltrating Lymphocytes Combined with IFN-α in Chinese Resected Stage III Malignant Melanoma
   Wei Li et al, 2017, Journal of Immunology Research CrossRef
10. Survival benefit from RectroNectin-activated cytokine-induced killer cells combined with chemotherapy in advanced EGFR wild-type lung adenocarcinoma
    Lingdi Zhao et al, 2018, Immunotherapy CrossRef